Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
2965 |
|
Actual shortage: | 237 (8%) | |
Anticipated shortage: | 27 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2692 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
25 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-RISPERIDONE | 0.50MG | TABLET | Actual shortage | 2023-11-10 | 2024-03-22 | 209957 |
APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-11-06 | 2024-03-22 | 209298 |
APO-IBUPROFEN | 400MG | TABLET | Actual shortage | 2024-03-15 | 2024-03-22 | 222470 |
APO-RIVASTIGMINE | 1.5MG | CAPSULE | Actual shortage | 2024-03-08 | 2024-03-22 | 221729 |
APO TRIAZIDE | 25MG 50MG | TABLET | Actual shortage | 2024-03-08 | 2024-03-22 | 221702 |
APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-02-16 | 2024-03-22 | 219840 |
APO-NAPROXEN | 500MG | TABLET | Actual shortage | 2024-02-09 | 2024-03-22 | 219171 |
APO-MIDODRINE | 2.5MG | TABLET | Actual shortage | 2024-02-09 | 2024-03-22 | 219162 |
ZAMINE 21 | 0.03MG 3MG | TABLET | Actual shortage | 2024-02-02 | 2024-03-22 | 218391 |
APO-HYDRALAZINE | 25MG | TABLET TABLET | Actual shortage | 2024-01-19 | 2024-03-22 | 216650 |
APO-PRAVASTATIN | 40MG | TABLET | Actual shortage | 2024-02-02 | 2024-03-22 | 218397 |
APO-MONTELUKAST | 10MG | TABLET | Actual shortage | 2024-02-23 | 2024-03-22 | 220456 |
APO-METOPROLOL | 25MG | TABLET | Resolved | 2024-01-05 | 2024-03-22 | 215233 |
APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-01 | 2024-03-22 | 221096 |
APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-01-19 | 2024-03-22 | 216653 |
APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-02-23 | 2024-03-22 | 220459 |
APO-DOXAZOSIN | 4MG | TABLET | Resolved | 2023-12-08 | 2024-03-22 | 212946 |
APO-BROMFENAC | 0.07% | SOLUTION | Resolved | 2024-01-19 | 2024-03-22 | 216678 |
APO-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-02-02 | 2024-03-22 | 218373 |
APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-12 | 2024-03-22 | 215973 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-NORTRIPTYLINE | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
APO-METOCLOP TAB 5MG | 5mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1105 |
APO-METOCLOP TAB 10MG | 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1101 |
APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
APO-DILTIAZ TZ | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1078 |
APO-DILTIAZ TZ | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1075 |
APO-DILTIAZ TZ | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1072 |
APO-DILTIAZ TZ | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1069 |
APO-DILTIAZ TZ | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1064 |
APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |